Recursion stock soars on $50M Nvidia investment, boosts peers (update)
koto_feja/E+ via Getty Images
Updates to add details 

Biotech firm Recursion (NASDAQ:RXRX) said on Wednesday that it had secured a $50M investment from Nvidia (NVDA), which was implemented as a private investment in public equity.
RXRX shares jump +72.7% in early trading.
Shares of peers Schrodinger (SDGR) rose +8.2% and Exscientia (EXAI) jumped 14.6%.

Recursion will utilize NVDA's cloud platform to train its AI models using its over 23 petabytes of biological and chemical dataset.
RXRX said it could potentially use its BioNeMo platform to commercially license or release its AI models.
The company had launched BioNeMo earlier this year as a cloud service for generative AI in drug discovery.
Press Release